Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limitedverified

SPARC.NS

Price:

$152.94

Market Cap:

$49.63B

Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops new chemical and biological entities, and reformulated products with a therapeutic focus on oncology, neurodegeneration, ophthalmology, and dermatology. The company offers Elepsia, a formulation of levetiracetam that is an anti-epileptic agent to treat epilepsy disorder; and Xelpros, a latanoprost ophthalmic emulsion for the treatment of open-angle glaucoma or ocular hypertension. In addition, it is developing SDN-037, a formulation of difluprednate for the treatment of inflammation and pain associated with ocu...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2003-01-14

Stock Exchange

NSE

Ticker

SPARC.NS

The ROE as of December 2025 (TTM) for Sun Pharma Advanced Research Company Limited (SPARC.NS) is 124.78%

According to Sun Pharma Advanced Research Company Limited’s latest financial reports and current stock price. The company's current ROE is 124.78%. This represents a change of 183.23% compared to the average of 44.06% of the last 4 quarters.

Sun Pharma Advanced Research Company Limited (SPARC.NS) Historical ROE (quarterly & annually)

How has SPARC.NS ROE performed in the past?

The mean historical ROE of Sun Pharma Advanced Research Company Limited over the last ten years is 45.60%. The current 124.78% ROE has changed 173.63% with respect to the historical average. Over the past ten years (40 quarters), SPARC.NS's ROE was at its highest in in the March 2020 quarter at 534.08%. The ROE was at its lowest in in the September 2021 quarter at -1168.22%.

Quarterly (TTM)
Annual

Average

45.60%

Median

-62.21%

Minimum

-651.37%

Maximum

1.68%

Sun Pharma Advanced Research Company Limited (SPARC.NS) ROE by Quarter and Year

Discovering the peaks and valleys of Sun Pharma Advanced Research Company Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 609.35%

Maximum Annual ROE = 1.68%

Minimum Annual Increase = -3514.21%

Minimum Annual ROE = -651.37%

Quarterly (TTM)
Annual
YearROEChange
2025157.88%-151.27%
2024-307.91%609.35%
2023-43.41%-93.34%
2022-651.37%-825.12%
202189.83%-94.64%
20201.68%-3514.21%
2019-49.09%-53.97%
2018-106.64%41.56%
2017-75.33%-67.82%
2016-234.07%491.08%

Sun Pharma Advanced Research Company Limited (SPARC.NS) Average ROE

How has SPARC.NS ROE performed in the past?

The current ROE of Sun Pharma Advanced Research Company Limited (SPARC.NS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-64.48%

5-year avg

-151.00%

10-year avg

45.60%

Sun Pharma Advanced Research Company Limited (SPARC.NS) ROE vs. Peers

How is SPARC.NS’s ROE compared to its peers?

Sun Pharma Advanced Research Company Limited’s ROE is greater than Suven Life Sciences Limited (-121.73%), greater than Suven Life Sciences Limited (-121.73%), less than Aarti Drugs Limited (14.52%), less than Aarti Drugs Limited (14.52%), less than RPG Life Sciences Limited (43.21%), less than RPG Life Sciences Limited (43.21%), less than Innova Captab Limited (12.98%), less than Orchid Pharma Limited (4.15%), less than Gufic Biosciences Limited (10.53%), less than Gufic Biosciences Limited (10.53%),

Build a custom stock screener for Sun Pharma Advanced Research Company Limited (SPARC.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sun Pharma Advanced Research Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sun Pharma Advanced Research Company Limited (SPARC.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sun Pharma Advanced Research Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Sun Pharma Advanced Research Company Limited's ROE?

How is the ROE calculated for Sun Pharma Advanced Research Company Limited (SPARC.NS)?

What is the highest ROE for Sun Pharma Advanced Research Company Limited (SPARC.NS)?

What is the 3-year average ROE for Sun Pharma Advanced Research Company Limited (SPARC.NS)?

What is the 5-year average ROE for Sun Pharma Advanced Research Company Limited (SPARC.NS)?

How does the current ROE for Sun Pharma Advanced Research Company Limited (SPARC.NS) compare to its historical average?